Heidelberg Pharma AG (HPHA) Income Statement
Heidelberg Pharma AG Income Statement
Last quarter (Q3 2026), Heidelberg Pharma AG's total revenue was $1.92M, an increase of 3974.60% from the same quarter last year. In Q3, Heidelberg Pharma AG's net income was $-5.26M. See Heidelberg Pharma AG’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| $ 1.46M | $ 6.85M | $ 9.86M | $ 18.51M | $ 2.90M | |
| $ -1.19M | $ 5.07M | $ 6.61M | $ 13.83M | $ -1.81M | |
| $ 46.26M | $ 25.73M | $ 27.82M | $ 31.02M | $ 23.33M | |
| Depreciation and Amortization | $ 2.82M | $ 871.22K | $ 879.00K | $ 756.58K | $ 802.86K |
| $ -44.63M | $ -14.48M | $ -18.71M | $ -16.19M | $ -24.35M | |
| $ -47.44M | $ -20.67M | $ -21.21M | $ -17.18M | $ -25.14M | |
| $ 6.21M | $ 1.28M | $ 863.31K | $ -604.67K | $ -1.00M | |
| $ -41.23M | $ -19.38M | $ -20.35M | $ -17.79M | $ -26.14M | |
| $ -42.28M | $ -19.38M | $ -20.35M | $ -19.70M | $ -26.14M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.91 | $ -0.42 | $ -0.44 | $ -0.53 | $ -0.82 |
| Diluted EPS | $ -0.91 | $ -0.42 | $ -0.44 | $ -0.53 | $ -0.82 |
| Weighted Average Shares Outstanding | 46.67M | 46.60M | 46.60M | 37.24M | 32.50M |
| Weighted Average Shares Outstanding (Diluted) | 46.67M | 46.60M | 46.60M | 37.24M | 32.50M |
Currency in EUR
